Impact of maintenance, resuscitation and unintended fluid therapy on global fluid load after elective coronary artery bypass surgery.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
02 2019
Historique:
received: 30 04 2018
revised: 05 10 2018
accepted: 28 10 2018
pubmed: 13 11 2018
medline: 18 2 2020
entrez: 13 11 2018
Statut: ppublish

Résumé

Standardized protocols are provided for maintenance and replacement fluid therapy in critically ill patients. However, unintended fluid sources (analgesics, antibiotics and other drugs) are not always taken into account when prescribing intravenous fluid therapy. We evaluated the extent to which maintenance, resuscitation and unintended fluids contributed to total fluid load in elective coronary artery bypass graft patients during their ICU stay. Data on intravenous and oral fluid input and output were retrospectively collected from the electronic medical files. Sixty patients were included. Maintenance fluids represented 1435 ± 570mL (49%) and 2214 ± 657mL (71%), resuscitation fluids 847 ± 542mL (29%) and 338 ± 559mL (11%), unintended fluids 639 ± 162mL (22%) and 576 ± 285mL (18%) respectively on day 1 and day 2. Mean oral intake increased almost fourfold (from 258mL to 1017mL) on the second day. Postoperative maintenance and resuscitation fluids are responsible for most of the observed total fluid load on the first two days after elective coronary artery bypass graft surgery. Unintended fluid load is underestimated and has to be taken into account during fluid prescription.

Identifiants

pubmed: 30419546
pii: S0883-9441(18)30611-7
doi: 10.1016/j.jcrc.2018.10.025
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-135

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Tina Maes (T)

Intensive Care Unit, University Hospital Brussels (UZB), Brussels, Belgium; Department of Anaesthesiology, University Hospital Brussels (UZB), Brussels, Belgium. Electronic address: Tina.Maes@uzbrussel.be.

Annelies Meuwissen (A)

Intensive Care Unit, University Hospital Brussels (UZB), Brussels, Belgium; Department of Internal Medicine, University Hospital Brussels (UZB), Brussels, Belgium.

Marc Diltoer (M)

Intensive Care Unit, University Hospital Brussels (UZB), Brussels, Belgium; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Duc Nam Nguyen (DN)

Intensive Care Unit, University Hospital Brussels (UZB), Brussels, Belgium; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Mark La Meir (M)

Department of Cardiac Surgery, University Hospital Brussels (UZB), Brussels, Belgium; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Robert Wise (R)

Pietermaritzburg Metropolitan Department of Anaesthetics, Critical Care and Pain Management, Pietermaritzburg, South Africa; Discipline of Anaesthesia and Critical Care, School of Clinical Medicine, College of Health Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Herbert Spapen (H)

Intensive Care Unit, University Hospital Brussels (UZB), Brussels, Belgium; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Manu L N G Malbrain (MLNG)

Intensive Care Unit, University Hospital Brussels (UZB), Brussels, Belgium; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Elisabeth De Waele (E)

Intensive Care Unit, University Hospital Brussels (UZB), Brussels, Belgium; Department of Nutrition, University Hospital Brussels (UZB), Brussels, Belgium; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH